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In this retrospective cohort study, we demonstrate that PCR-confirmed diagnoses of influenza were made solely by lower
respiratory sampling in 6.9% of cases, as traditional upper respiratory tract tests were negative, indeterminate or not
performed. Clinical features of these cases are presented. Clinicians should consider lower respiratory tract sampling in
select cases of influenza-like illness for diagnosis.
Introduction
Clinicians are often faced with the challenge of patients presenting
with an influenza-like syndrome despite negative routine
influenza investigations. These investigations usually include nasal
or nasopharyngeal rapid influenza screens, direct fluorescent
antibody (DFA) or PCR tests. Occasionally these diagnostic tests
may be falsely negative due to their low sensitivity, as in the case
of many rapid-influenza tests,
1 poor technique in specimen
collection, delayed transport to the laboratory or the presence of
viral inhibitors.
2 Clinicians rely heavily on these investigations as
they are readily available and guide therapeutic decisions.
Most influenza infections affect the upper respiratory tract,
while lower tract infection typically represents extension from
upper airways and may be diagnosed with lower respiratory
sampling such as bronchoscopy.
2,3 Occasionally a diagnosis of
influenza is missed with upper respiratory tract sampling if
pulmonary symptoms are present, and concerns have been raised
regarding missing pandemic strain of H1N1
4 and Avian influenza
A (H5N1), which have both been shown to infect the lower
respiratory tract.
5,6 We present data from our institution where
lower respiratory tract sampling aided the diagnosis of influenza
and discuss clinical features of these patients.
Methods
The Institutional Review Board at the Massachusetts General
Hospital reviewed and approved this study. We performed a
retrospective cohort analysis of all cases of PCR-confirmed
influenza between December 2009 and April 2011 at the
Massachusetts General Hospital [Simplexa
TM Influenza A
H1N1 (2009), Focus Diagnostics]. We identified all patients
where lower respiratory sampling (induced sputum, endotracheal
aspiration or bronchoscopy) was used to diagnose influenza. Only
cases that were confirmed as PCR-positive were included. Using a
standardized data collection form, we recorded patient demo-
graphics, influenza diagnostic testing, radiographic features,
oxygenation supplementation, clinical features, accompanying
comorbid conditions, and outcomes. Obesity was defined by body
mass index (BMI) equal to or greater than 30. Patients were
defined as immunocompromised if they were taking prednisone
(or equivalent) . 15 mg per day for over 2 mo, on active
chemotherapy, HIV with CD4 T cell counts less than 200 cells/
ml or on other immunomodulatory medications such as biologic
therapies like tumor necrosis factor a antagonists.
Results
One hundred and sixteen patients were identified with PCR-
confirmed influenza virus between December 2009 and April
2011. Forty-six were typed as pandemic H1N1 and 70 as seasonal
influenza A. The average age was 56.6 y (range 1–95) with 60
(51.7%) females. Ninety-four patients (81%) were hospitalized
and a total of 6 (5.1%) of died. Sixty-seven (57.8%) had a
comorbid condition portending severe influenza. Of these 116
PCR-positive patients, 15 (12.9%) underwent lower respiratory
sampling to aid in diagnosis (age range 11–81 y). Ten of these 15
patients (66.7%) were positive for influenza virus in lower
respiratory samples. Of these 10, a diagnosis of influenza was
made solely by lower respiratory sampling in eight cases (6.9% of
total PCR positive cases), as rapid tests, nasopharyngeal DFA or
PCR tests were either negative, indeterminate or not performed
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82 Virulence Volume 4 Issue 1(Table 1). Those with positive lower respiratory sampling had an
average age of 48.3 y (range 21–81), and were predominantly
female (70%). Eight of the 10 patients were receiving oseltamivir
at the time of lower respiratory sampling. Seven (70%) patients
presented with fever, and the average white blood cell count on
presentation was 7.3 cells/ml (range 3.2–16.2) on admission.
Radiographic features included 6 (60%) with acute respiratory
distress syndrome (ARDS), and 3 (30%) with single or multi
lobar consolidative processes. One patient had no obvious
radiographic changes from his underlying interstitial lung disease.
Eight (80%) patients required care in an ICU and two (20%)
patients ultimately died of their illness.
Discussion
Influenza viruses initially infect the upper airways but can directly
extend to the lower airways in severe cases, resulting in a viral
pneumonia with significant morbidity and mortality.
4 Patients
initially present with upper respiratory symptoms, but typically
deteriorate from a respiratory standpoint if lower tract symptoms
develop, frequently requiring hospitalization or intensive care.
Clinicians should be aware that sampling of the upper airways
might not be adequate to diagnose these cases. In our series, 6.9%
of PCR-documented influenza had negative upper airway
sampling, and were diagnosed by either BAL, endotracheal
aspiration, or induced sputum. Certain influenza strains such as
Avian H5N1 virus
6 are reported to infect lower airways, and case
reports suggest that pandemic H1N1 may have a predilection for
lower airways as well.
1,5 Indeed, recent studies suggest that
mutations to pandemic H1N1 such as D222G/N result in
exclusively lower respiratory tract disease.
7 This is concerning as it
highlights the possibility for future circulating influenza strains to
preferentially infect the lower respiratory tract, and clinicians
should be aware that lower-tract sampling may be necessary to
make or confirm an influenza diagnosis. It is difficult to ascertain
if our case series supports the theory that pandemic H1N1 has a
higher probability than seasonal influenza for infecting the lower
respiratory tract given the descriptive and retrospective nature;
however, 70% of our samples from lower tract cases were
confirmed as pandemic H1N1 influenza, yet this only made up
39.7% of all PCR-typed influenza diagnoses.
A weakness of this study is that it is retrospective and the
prevalence of lower respiratory tract samples positive for influenza
may be underestimated here. Many more patients may have lower
respiratory tract disease but were not tested. We also only looked
at cases of influenza that were PCR positive, and likely excluded
several cases that had negative diagnostic tests. It is not clear why
the five patients with lower respiratory tract symptoms who
underwent BAL had negative PCR specimens. These may be
related to specimen sampling, transportation or processing errors.
Several types of viral pneumonia have been diagnosed via lower
respiratory tract sampling. In a primarily immunocompromised
cohort of patients with pneumonia, Connoly et al.
8 utilized BAL
and culture techniques to diagnose a viral etiology in 615 out of
1,199 specimens. Eleven of these cases were influenza (nine with
type A and two with type B). In addition to bronchoscopy,
endotracheal aspirates in intubated patients may also be effective
in diagnosing lower tract influenza. A small case series from
California reported three patients with negative influenza PCR on
nasopharyngeal swabs, but positive PCR for pandemic H1N1
influenza with endotracheal aspirates.
9 Two patients in our series
were diagnosed by endotracheal aspirate, both of whom had
pandemic H1N1 infection. Other helpful diagnostic methods for
influenza A include PCR from sputum samples, without the aid of
lower respiratory tract sampling. Falsey et al. recently demon-
strated the identification of respiratory viruses (primarily influenza
A) in 36% of sputum samples tested with PCR compared with
23% of nasopharyngeal samples tested with PCR.
10
Unfortunately, sputum samples are often difficult to obtain, and
could only be acquired in 73% of patients.
There are several reasons why results from traditional influenza
diagnostic tests may be negative in cases of influenza. Appropriate
Table1. Characteristics of patients with lower respiratory specimens positive for influenza A (pandemic and seasonal)
Patient Age (y) Sex Rapid test NP DFA NP PCR Comorbidities Lower respiratory tract
sampling
Outcome
Number in brackets denotes
number of specimens
1 31 F -(1) -(1) n/a Nil ETA Died
2 59 F n/a -(2) n/a Renal transplant BAL Survived
3 21 F n/a -(2) + Pregnant, obese BAL Survived
4 49 F n/a + + ILD BAL Survived
5 54 F -(1) -(1) i(1) Nil BAL Survived
6 26 F -(2) -(2) -(1) Nil BAL Survived
7 73 M n/a -(1) n/a ILD BAL Died
8 37 F n/a -(1) n/a Nil ETA Survived
9 81 M n/a -(1) n/a Nil BAL Survived
10 52 M -(1) -(1) -(1) HIV, asthma IS Survived
NP, nasopharyngeal; DFA, direct fluorescent antibody; i, indeterminate; BAL, bronchoalveolar lavage; ETA, endotracheal aspirate; IS, induced sputum;
ILD, interstitial lung disease
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tests may ultimately be negative due to inadequate specimen
collection. Other possibilities include low levels of viral shedding
in the nasopharynx at the time of sampling as the infection has
progressed to the lower respiratory tract.
2 Animal models
demonstrate more viral replication in the trachea, bronchi and
bronchioles with pandemic H1N1 compared with seasonal
H1N1, which is restricted primarily to the nasopharynx.
11
Lastly, those with risk factors for severe influenza such as obesity,
an immunocompromised state, asthma or pregnancy
12 may be at
greater risk of lower respiratory tract involvement and a poor
prognosis. Future prospective studies should assess diagnostic
characteristics of influenza in relation to the time of sample
collection, risk factors for severe disease and clinical disease
progression.
Traditional nasopharyngeal diagnostic techniques may miss
cases of influenza affecting the lower respiratory tract. Clinicians
should have a high degree of suspicion in patients with lower-tract
symptoms and a syndrome compatible with influenza, particularly
in the setting of pregnancy, obesity or in immunocompromised
states. Empiric antiviral therapy is often warranted
13 and sampling
of the lower tract by bronchoscopy, endotracheal aspirate or
induced sputum may yield a diagnosis.
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